Hypomethylating Agents and FLT3 Inhibitors As Maintenance Treatment for Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation–A Systematic Review and Meta-Analysis - Transplantation and Cellular
4.5
$ 13.00
In stock
(283)
Product Description
Hypomethylating Agents and FLT3 Inhibitors As Maintenance Treatment for Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation–A Systematic Review and Meta- Analysis - Transplantation and Cellular
The Evolving Treatment Landscape of AML Published in healthbook TIMES Oncology Hematology
How I treat acute myeloid leukemia in the era of new drugs - ScienceDirect
Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies
Frontiers Maintenance With Hypomethylating Agents After Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis
Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
IJMS, Free Full-Text
Advances and Future Goals in Acute Myeloid Leukaemia Therapy - touchONCOLOGY
PDF) Allogeneic transplant for FLT3 - ITD mutated AML: a focus on FLT3 inhibitors before, during, and after transplant
PDF) Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
New drugs before, during, and after hematopoietic stem cell transplantation for patients with acute myeloid leukemia
Hypomethylating Agents and FLT3 Inhibitors As Maintenance Treatment for Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation–A Systematic Review and Meta- Analysis - ScienceDirect
Hypomethylating agents are effective in myelodysplastic syndrome
